Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose versus oral ferrous sulfate for antenatal anaemia in Bangladesh
ACTRN12621000968875Phase 3Completed
- Sponsor
- icddr,b
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ferric carboxymaltose and ferrous sulfate in iron deficiency anemia (IDA) and anaemia, sponsored by icddr,b. Started Oct 2022; status: completed.
02
Drugs
ferric carboxymaltoseferrous sulfate
03
Conditions
iron deficiency anemia (IDA)anaemia
Beyond the preview
Go deeper on ACTRN12621000968875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000968875.